Comparative effectiveness of biguanides versus SGLT2 inhibitors on cardiovascular and cerebrovascular events, diabetic nephropathy, retinopathy, neuropathy, and treatment expenditures in patients with type 2 diabetes - Eiji Nakatani; Hiromitsu Ohno; Takayoshi Nagahama; Toru Tonoike; Hiromichi Yui; Tatsunori Satoh; Taku Matsunaga; Daito Funaki; Chikara Ueki; Emi Ohata; Akinori Miyakoshi; Ataru Igarashi; et al. (PLoS ONE, 2025)